← Back to all trials
Not Yet Recruiting
NCT05676866
Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
Conditions: Node-positive Breast Cancer
Sex: Female
Ages: 15 Years – 70 Years
Healthy volunteers: 1
Phase: PHASE4
Enrollment: 30
Sponsor: Assiut University
Summary
evaluation of targeted axillary lymph node dissection in node positive breast cancer patients post neo adjuvant therapy
Eligibility Criteria
Inclusion Criteria:females with invasive breast cancer with axillary metastasis, staging of n1: n2complete axillary response to neoadjuvant therapy by clinical examination and imagingExclusion Criteria:1. breast cancer patients who are not candidate for neoadjuvant chemotherapy 2. breast cancer patients with positive axillary node post neoadjuvant chemotherapy 3. breast cancer patients with distant metastasis 4. patients with axillary lymph node metastasis from another primary tumour [not breast cancer]
Source: ClinicalTrials.gov (NCT05676866). StuddyBuddy aggregates publicly available trial information.
